Deborah J. Allen
13Patents
13h-index
14Co-inventors
71Inventor score
Filing activity: Feb 9, 1996 → Jun 15, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6090382A | Human antibodies that bind human TNF.alpha. | Emerging Cross-Sectional Technologies | 444 | Expired |
| US6258562A | Human antibodies that bind human TNF.alpha. | Emerging Cross-Sectional Technologies | 307 | Expired |
| US6509015B1 | Human antibodies that bind human TNFa | Emerging Cross-Sectional Technologies | 211 | Expired |
| US7223394B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 160 | Expired |
| US7541031B2 | Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 147 | Active |
| US7588761B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 143 | Expired |
| US5872215A | Specific binding members, materials and methods | Chemistry; Metallurgy | 83 | Expired |
| US8414894B2 | Human antibodies that bind human TNFα and methods of using same | Emerging Cross-Sectional Technologies | 73 | Active |
| US8206714B2 | Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa | Emerging Cross-Sectional Technologies | 72 | Active |
| US8197813B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 71 | Active |
| US8372401B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 70 | Active |
| US8372400B2 | Methods of treating disorders using human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 69 | Active |
| US8753633B2 | Human antibodies that bind human TNFα | Emerging Cross-Sectional Technologies | 49 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.